Effects of Hoodia Parviflora on satiety, abdominal obesity and weight in a group of overweight subjects: a randomized, blinded, placebo-controlled trial.


Journal

Minerva gastroenterologica e dietologica
ISSN: 1827-1642
Titre abrégé: Minerva Gastroenterol Dietol
Pays: Italy
ID NLM: 9109791

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 29 3 2020
medline: 9 7 2021
entrez: 29 3 2020
Statut: ppublish

Résumé

This study aimed to assess the effects of supplementation with Hoodia Parviflora (H. Parviflora) at 9 mg+200 mg of fructo-oligosaccharides on weight loss, body composition, hydration and satiety parameters. A randomized blinded controlled trial was conducted in a sample of 30 overweight and obese patients (5 males and 25 females). Patients were randomly assigned in 2 groups: the intervention group, which received H. Parviflora twice a day for 4 weeks and the control group, which received a placebo. After a 4-week follow-up period, the study results showed an improvement of Δ=-1.632 kg (Confidence Interval [CI]95% -2.545; -0.719) and a statistically significant decrease in waist circumference (WC) compared with the placebo group -2.080 cm ([CI]95% -4.082; -0.078). The visual analogue scale reported an improvement of satiety sensation after day 5 (P=0.001). This study shows for the first time the simultaneous effect of H. Parviflora on weight loss, decreasing satiety, and improving fat mass, in particular Visceral Adipose Tissue (VAT).

Sections du résumé

BACKGROUND BACKGROUND
This study aimed to assess the effects of supplementation with Hoodia Parviflora (H. Parviflora) at 9 mg+200 mg of fructo-oligosaccharides on weight loss, body composition, hydration and satiety parameters.
METHODS METHODS
A randomized blinded controlled trial was conducted in a sample of 30 overweight and obese patients (5 males and 25 females). Patients were randomly assigned in 2 groups: the intervention group, which received H. Parviflora twice a day for 4 weeks and the control group, which received a placebo.
RESULTS RESULTS
After a 4-week follow-up period, the study results showed an improvement of Δ=-1.632 kg (Confidence Interval [CI]95% -2.545; -0.719) and a statistically significant decrease in waist circumference (WC) compared with the placebo group -2.080 cm ([CI]95% -4.082; -0.078). The visual analogue scale reported an improvement of satiety sensation after day 5 (P=0.001).
CONCLUSIONS CONCLUSIONS
This study shows for the first time the simultaneous effect of H. Parviflora on weight loss, decreasing satiety, and improving fat mass, in particular Visceral Adipose Tissue (VAT).

Identifiants

pubmed: 32218424
pii: S1121-421X.20.02669-0
doi: 10.23736/S1121-421X.20.02669-0
doi:

Substances chimiques

Plant Extracts 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

211-218

Auteurs

Simone Perna (S)

Department of Biology, College of Science, University of Bahrain, Sakhir, Bahrain.

Vittoria Infantino (V)

Unit of Human and Clinical Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.

Gabriella Peroni (G)

Unit of Endocrinology and Nutrition, Azienda di Servizi alla Persona Istituto Santa Margherita, University of Pavia, Pavia, Italy - gabriella.peroni01@universitadipavia.it.

Clara Gasparri (C)

Unit of Endocrinology and Nutrition, Azienda di Servizi alla Persona Istituto Santa Margherita, University of Pavia, Pavia, Italy.

Milena A Faliva (MA)

Unit of Endocrinology and Nutrition, Azienda di Servizi alla Persona Istituto Santa Margherita, University of Pavia, Pavia, Italy.

Maurizio Naso (M)

Unit of Endocrinology and Nutrition, Azienda di Servizi alla Persona Istituto Santa Margherita, University of Pavia, Pavia, Italy.

Tariq A Alalwan (TA)

Department of Biology, College of Science, University of Bahrain, Sakhir, Bahrain.

Filippo Borsani (F)

PromoPharma S.p.A. Acquaviva, San Marino, Italy.

Martina Berardi (M)

PromoPharma S.p.A. Acquaviva, San Marino, Italy.

Zahra Ilyas (Z)

Department of Biology, College of Science, University of Bahrain, Sakhir, Bahrain.

Zahraa Alaali (Z)

Department of Biology, College of Science, University of Bahrain, Sakhir, Bahrain.

Layla Alsowaid (L)

Department of Biology, College of Science, University of Bahrain, Sakhir, Bahrain.

Daniele Spadaccini (D)

Unit of Endocrinology and Nutrition, Azienda di Servizi alla Persona Istituto Santa Margherita, University of Pavia, Pavia, Italy.

Mariangela Rondanelli (M)

Unit of Human and Clinical Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.
IRCCS Mondino Foundation, Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH